1210.1000 3.20 (0.27%)
NSE Jan 09, 2026 15:31 PM
Volume: 1.4M
 

1210.10
0.27%
Axis Direct
The Sputnik-V vaccine has been given Emergency Use Authorization by the Indian govt. The vaccine has a proven efficacy rate of 91.5 percent, which is the highest after the candidates of Moderna Inc and Pfizer-BioNTech. The cost of Sputnik V could be in the range of $3.5 per dose.
Number of FII/FPI investors decreased from 917 to 872 in Sep 2025 qtr
More from Dr. Reddy's Laboratories Ltd.
Recommended